Axe Compute Inc. (AGPU): Nasdaq/NYSE listing notice — Predictive Oncology receives Nasdaq extension to May 8, 2023 to meet $1 bid price rule

Axe Compute Inc.

Nasdaq granted a 180-day extension until May 8, 2023 for the company to regain compliance with the $1 minimum bid price rule.
Company still not in compliance; had previously received a deficiency notice on May 13, 2022.
To cure, the company may effect a reverse stock split; failure could lead to delisting and an appeal.
Extension conditional on meeting all other Nasdaq listing requirements; company currently meets those.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Axe Compute Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

November 10, 2022, Nasdaq notified the Company that while the Company had not regained compliance with the Minimum Bid Price Requirement, it is eligible for an additional 180-day calendar period, or until May 8, 2023, to regain compliance. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and the Company’s written notice to Nasdaq of its intention to cure the deficiency d

View on SEC.gov

Browse all listing & compliance notices →

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-22-007357

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.